Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-EEF2 Antibody (R3D23)

Catalog #:   RHC99105 Specific References (30) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, IF, IHC, WB
Accession: P13639
Overview

Catalog No.

RHC99105

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, IF: 1:200-1:1000, IHC: 1:200-1:1000, WB: 1:500-1:2000

Target

EF-2, EF2, EEF2, Elongation factor 2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P13639

Applications

ELISA, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3D23

Data Image
  • Immunofluorescence
    Immunofluorescence analysis of 3T3-L1 cells using EEF2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human liver cancer tissues (left) and kidney cancer tissues (right) using EEF2 mouse mAb with DAB staining.
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human prostate cancer tissues (left) and tonsil tissues (right) using EEF2 mouse mAb with DAB staining.
  • Western blot
    Western blot analysis using EEF2 mouse mAb against HepG2 (1), Hela (2), HEK293 (3) and A431 (4) cell lysate.
References

Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies., PMID:40240912

The FAM86 domain of FAM86A confers substrate specificity to promote EEF2-Lys525 methylation., PMID:37209825

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties., PMID:32182799

Eukaryotic elongation factor 2 is involved in the anticoccidial action of diclazuril in the second-generation merozoites of Eimeria tenella., PMID:31770701

mTORC1 Signaling in Individual Human Muscle Fibers Following Resistance Exercise in Combination With Intake of Essential Amino Acids., PMID:31294029

eEF-2 Kinase-targeted miR-449b confers radiation sensitivity to cancer cells., PMID:29331413

Depression of leukocyte protein synthesis, immune function and growth performance induced by high environmental temperature in broiler chickens., PMID:28455634

Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADPRibosylating Toxins., PMID:28245596

Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus., PMID:27834892

An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates., PMID:27163177

Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease., PMID:26621506

BDNF - a key transducer of antidepressant effects., PMID:26519901

PP2A inhibition overcomes acquired resistance to HER2 targeted therapy., PMID:24958351

The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers., PMID:24589652

Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers., PMID:24130777

HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors., PMID:21791637

Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells., PMID:21554491

Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition., PMID:20300520

Identification of melanoma antigens using a Serological Proteome Approach (SERPA)., PMID:20181627

Oxytocin receptor signalling., PMID:18655881

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray., PMID:18161940

Quantification of diphtheria toxin mediated ADP-ribosylation in a solid-phase assay., PMID:17712004

Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain., PMID:16098202

High hydrostatic pressure inhibits the biosynthesis of eukaryotic elongation factor-2., PMID:15534876

Identification of a hypothetical membrane protein interactor of ribosomal phosphoprotein P0., PMID:15286401

Effect of serum and hydrogen peroxide on the Ca2+/calmodulin-dependent phosphorylation of eukaryotic elongation factor 2(eEF-2) in Chinese hamster ovary cells., PMID:11795480

Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons., PMID:9133370

Elongation factor-2 kinase: immunological evidence for the existence of tissue-specific isoforms., PMID:8941713

Interaction of the calcium and calmodulin regulated eEF-2 kinase with heat shock protein 90., PMID:8050573

High-resolution one-dimensional polyacrylamide gel isoelectric focusing of various forms of elongation factor-2., PMID:1519762

Datasheet

Document Download

Anti-EEF2 Antibody (R3D23).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-EEF2 Antibody (R3D23) [RHC99105]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only